Milestone Pharmaceuticals
MIST
MIST
44 hedge funds and large institutions have $22.9M invested in Milestone Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
0.59%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
11
Increased
10
Reduced
9
Closed
10
Calls
$743K
Puts
$81K
Net Calls
+$662K
Net Calls Change
+$423K
Top Buyers
| 1 |
PBM
Propel Bio Management
Los Angeles,
California
|
+$660K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$410K |
| 3 |
SAM
Simplify Asset Management
Las Vegas,
Nevada
|
+$272K |
| 4 |
Goldman Sachs
New York
|
+$232K |
| 5 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
+$215K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$287K |
| 2 |
Millennium Management
New York
|
-$258K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$207K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$200K |
| 5 |
LPL Financial
San Diego,
California
|
-$195K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CCFM
51
Clear Creek Financial Management
Silverdale,
Washington
| – | -$8.4K | -10,500 | Closed |
|
|
IWC
52
Integrated Wealth Concepts
Waltham,
Massachusetts
| – | -$8K | -10,000 | Closed |
|
53
JPMorgan Chase & Co
New York
| – | -$2.61K | -3,266 | Closed |
|
54
Citigroup
New York
| – | -$2 | -2 | Closed |
|